Journal of Thyroid Disorders & Therapy
Open Access

Slimane Zerdoud

Biography

Dr. Slimane Zerdoud is a distinguished nuclear medicine physician at the University Institute of Cancer of Toulouse, Institut Claudius Regaud, in Toulouse, France. He specializes in the diagnosis and treatment of thyroid cancers, with a particular focus on the application of nuclear medicine techniques. Throughout his career, Dr. Zerdoud has contributed significantly to the field of nuclear medicine through both clinical practice and research. He has been involved in several pivotal studies aimed at improving the management of thyroid cancer. Notably, he co-authored a phase II trial investigating the efficacy of combining dabrafenib and trametinib with radioactive iodine therapy in patients with metastatic radioactive iodine-refractory BRAF p.V600E-mutated differentiated thyroid cancer. This study provided valuable insights into potential redifferentiation therapies for resistant thyroid cancers. In another significant publication, Dr. Zerdoud examined the variations in radioiodine therapy practices across Europe, highlighting the inconsistencies and uncertainties in treatment decisions for differentiated thyroid cancer. This work underscored the need for standardized guidelines to optimize patient outcomes.

Publications

• Case Report
  Report of a Track Seeding of Thyroid Papillary Carcinoma During Robot- Assisted Transaxillary Thyroidectomy
  Author(s): Emilien Chabrillac, Slimane Zerdoud, Pierre Graff-Cailleaud, Sébastien Fontaine and Jérôme Sarini Emilien Chabrillac, Slimane Zerdoud, Pierre Graff-Cailleaud, Sébastien Fontaine and Jérôme Sarini
  
  Background: The Robotic Thyroidectomy (RT) is a minimally invasive surgical technique initially developed in Asia, for cultural reasons. The principles of its use are still undergoing development. Showing to all appearances satisfying outcomes, the long-time safety and medico-economic benefit of the procedure have not been established yet. The use of this technique in thyroid carcinology remains rare, and provides specific risks, not encountered with the Open Thyroidectomy (OT). Patient Findings: We report the case of a patient who underwent a two-stages RT for a pT3 follicular carcinoma causing dissemination along the surgical track, in spite of the radioactive iodine treatment. Summary: This case reminds us the limits of the RT in the oncologic field and the lack of perspective, with the recent discovery of the r.. View More»
  DOI: 10.4172/2167-7948.1000218

  Abstract PDF

Relevant Topics